Connecticut's hemp farmers would be allowed a path into the cannabis industry under legislation that passed overwhelmingly Tuesday in a key legislative committee. The amended bill, which next moves to the state House of Representatives, would let dozens of small hemp growers apply for state cultivator or micro-cultivator licenses under the Department of Consumer Protection's cannabis program. The legislative General Law Committee approved the bill after a brief debate. The action occurred following a recent public hearing in which farmers said that during the few… Read more.
Your daily dose of news & information.
Lawmakers Across The Country File More Psychedelics Reform, Drug Decriminalization And Safe Consumption Site Bills
The first two months of 2023 have shown expansive interest in bold drug policy reform in state legislatures across the country—most recently, with the introduction of numerous new bills touching on everything from psychedelics legalization to authorizing safe drug consumption sites. Lawmakers in several states will conduct hearings on such reform proposals over the next week. The marijuana legalization movement continues to spread and evolve, but it’s become quickly apparent this session that legislators are eager to more holistically move… Read more.
Connecticut may establish a Cannabis Ombudsman position for the state’s medical cannabis program, which would be an independent liaison between patients and the state to address concerns about the program. A bill proposed in Connecticut would create the position of Cannabis Ombudsman – an independent person that would serve as a liaison between medical cannabis patients and the state to address concerns, NBC Connecticut reports. The move comes about a month after adult-use cannabis sales commenced in the state which has caused complaints among… Read more.
As many U.S. states adopt policies that legalize the commercialization of cannabis, Yale School of Medicine recently announced the creation of the new Yale Center for the Science of Cannabis and Cannabinoids, which will investigate the acute and chronic effects of cannabis and cannabinoids on neurodevelopment and mental health. Its inaugural director will be Deepak Cyril D’Souza, the Albert E. Kent Professor of Psychiatry and an expert in the pharmacology of cannabinoids. The new center comes just as retail cannabis sales begins in… Read more.